Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma
Clinical trial NCT06803875 · RECRUITING
Trial details
- NCT number
- NCT06803875
- Sponsor
- Roberto Chiarle
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-31
- Primary completion
- 2027-12-31
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.